Board of Directors

Charles R. Trimble, Chairman of the Board

Charles R. Trimble, Chairman of the Board

Charles Trimble is the founder and former CEO of Trimble Navigation, Ltd., a leading developer of commercial equipment utilizing the Global Positioning System (GPS). He led the company from a start-up in 1978 through a public offering in 1990. Trimble Navigation was largely responsible for creating the commercial GPS industry. At the time of Trimble’s departure in 1998, the company was the dominant worldwide supplier of GPS equipment. Since then he has mentored start-ups and served on boards of directors, both public and private..

Mr. Trimble is a member of the National Academy of Engineering and the Council on Foreign Relations. He served on the NASA Advisory Council, the National Electronics Manufacturing Initiative, and as chairman of the United States Global Positioning System Industry Council. Trimble is the past chairman and currently a member of the Jet Propulsion Laboratory(JPL) Committee of Caltech’s Board of Trustees. He has served as a Caltech Trustee since June, 2002 and he is Chairman of the Caltech’s Biology and Biological Engineering Chair Council, a group of individuals involved with funding cutting edge biotech research who advise the Division Chairman and have access to professors.

Mr. Trimble is the recipient of numerous awards and honors, including Inc. magazine’s Entrepreneur of the Year in 1991, the American Electronics Association Medal of Achievement in 2000, the Piper General Aviation Award from the American Institute of Aeronautics and Astronautics, the NASA Public Service Medal in 2001 and 2004, the Von Karman International Wings Award in 2016.

Trimble earned his BS in engineering in 1963, his MS in electrical engineering in 1964, the Distinguished Alumni Award from the California Institute of Technology.

Peter S. Lu

Peter S. Lu, M.D., Founder and Chief Executive Officer

Dr. Lu founded Arbor Vita Corporation in 1998 to develop novel therapeutics and diagnostics using PDZ proteins.

Previously, he held various appointments at Stanford University’s School of Medicine. As a Clinical Instructor in the Department of Dermatology, he directed the Psoriasis Treatment Center. Simultaneously, he founded and directed the Papua New Guinea Medical Project, leading teams of physicians and students into the jungles on medical relief efforts.

Dr. Lu holds an M.D. (with honors) and an M.S. in microbiology and immunology from the University of Washington’s School of Medicine and a B.S. in biology from the California Institute of Technology (Caltech). As a board-certified dermatologist, he completed his residency training at Stanford University’s School of Medicine and received post-doctoral training in the laboratory of Dr. Mark Davis at Stanford’s Howard Hughes Medical Institute.

Joseph T. Lu

Joseph T. Lu, M.D., Board Member

Dr. Lu is a neonatology pioneer and an international expert in neonatal jaundice with publications in Nature and Pediatrics. He served on the faculty at National Taiwan University and the University of Southern California and was a Visiting Scientist at Johns Hopkins University.

Dr. Lu established the first Southern California community hospital neonatal intensive care units (Huntington Memorial Hospital and Garfield Hospital) and for many years served as the Chairman of Pediatrics at Garfield Hospital.

Dr. Lu received his M.D. from National Taiwan University and completed his residency training at Huntington Memorial Hospital and Los Angeles County – University of Southern California Medical Center. He is currently in private practice.

Thomas D. Recine

Thomas D. Recine, M.B.A., Board Member

Mr. Recine has over forty year of experience in high tech. After starting his career at Motorola, he joined Silicon Valley giant National Semiconductor in 1970 where his last position was Director of Sales Operations. In 1982 he then co-founded Flagship Software and later Marcon Sales Inc. where he served as CEO. In 1991, he became Vice President of Marketing for the Linear Technology Corporation until he retired in 1996, and in 2001, he was a Director of Ingenuus Corporation.

Mr Recine received his B.S. in physics from the University of Windsor (Ontario, Canada) and his M.B.A. from Northeastern University. He currently serves on several non-profit boards.

Jon S. Saxe

Jon S. Saxe, J.D., Board Member

Mr. Saxe spent almost 30 years with Hoffmann-LaRoche Inc. and is former Vice President of Licensing and Corporate Development and Head of Patent law. From 1989 to 1993, he became president and CEO of Synergen Inc., a biotechnology company. As president of Saxe Associates from 1993 to 1995, he served as a consultant to venture capital firms and biotechnology, diagnostic, and pharmaceutical companies. From 1995 to 1999, he was president of PDL  BioPharma (formerly Protein Design Labs).

Mr. Saxe received his B.S. in biochemical engineering from Carnegie Mellon University, his J.D. from George Washington University’s School of Law, and his LL.M. from New York University’s School of Law. He serves as a director for several public and private companies, including Durect Corporation, VistaGen Therapeutics, and SciClone Pharmaceuticals.

Management Team

Peter Lu

Peter S. Lu, M.D., Founder and Chief Executive Officer

Dr. Lu founded Arbor Vita Corporation in 1998 to develop novel therapeutics and diagnostics using PDZ proteins.

Previously, he held various appointments at Stanford University’s School of Medicine. As a Clinical Instructor in the Department of Dermatology, he directed the Psoriasis Treatment Center. Simultaneously, he founded and directed the Papua New Guinea Medical Project, leading teams of physicians and students into the jungles on medical relief efforts.

Dr. Lu holds an M.D. (with honors) and an M.S. in microbiology and immunology from the University of Washington’s School of Medicine and a B.S. in biology from the California Institute of Technology (Caltech). As a board-certified dermatologist, he completed his residency training at Stanford University’s School of Medicine and received post-doctoral training in the laboratory of Dr. Mark Davis at Stanford’s Howard Hughes Medical Institute.

Johannes Schweizer

Johannes G. Schweizer, Ph.D., Chief Science Officer

Dr. Schweizer joined Arbor Vita shortly after its inception. Dr. Schweizer has a broad background in molecular biology with a focus on epigenetic mechanisms of gene regulation and in-vitro diagnostics applications for proteomics. Dr. Schweizer initiated work on Arbor Vita’s PDZ platform technology and currently manages the company’s research programs, specifically Arbor Vita’s Cervical Cancer Program and associated international relationships.

Dr. Schweizer received his M.S. and Ph.D from the University of Konstanz, Germany. His master’s degree is in biology with a focus in molecular genetics. His doctoral work was performed at the Pasteur Institute’s Department of Retrovirology. He performed his postdoctoral fellowship in the laboratory of Dr. Uta Francke at Stanford University’s Howard Hughes Medical Institute. Dr. Schweizer is the inventor of 14 issued patents.